LKFT

Conviction 66HealthcareScan · Thu, Sep 24, 2026

Lakefront Biotherapeutics NV (LKFT) closed at $30.38 (-1.11%) on Sep 24, 2026. Price is above its 50-day. RSI(14) 62, -1.4% from its 52-week high, +6.3% year to date. Sector: Healthcare · Biotechnology.

LKFT$30.38-1.11%

ResistanceSupportVol 14

Vol MA14 374.26K

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

Lakefront Biotherapeutics NVBiotechnologywww.lakefrontbio.com ↗

Price30.38

Change-1.11%

Gap-2.73%

Rel volume1.81×

Avg volume321.59K

Avg $ vol9.25M

SMA 2028.54

SMA 5028.27

SMA 200—

Price vs 50+7.45%

Price vs 200—

MA stack—

50/200 cross—

Supertrendup · 28.68

RSI (14)62

MACD hist0.32

MACD crossbull · 4d

Stoch %K / %D65 / 78

ADX (14)24

+DI / −DI44 / 19

RSI divergence—

MACD divergence—

ATR %2.93%

ADR %2.47%

52w high30.81

52w low26.08

From 52w high-1.40%

Above 52w low+16.49%

New 52w highNo

SqueezeOff

Bollinger width16.02%

%B0.90

Donchian pos64.88%

Donchian high32.41

Donchian low26.63

AVWAP (52w high)30.81

vs AVWAP high-1.41%

AVWAP (52w low)28.50

vs AVWAP low+6.59%

OBV trendFlat

Chaikin MF (20)-0.02

Today vs 20d1.81×

Avg vol (14d)374.26K

Avg vol (20d)321.59K

Avg $ vol (20d)9.25M

Market cap2B

RS Rating—

RS 3m (vs SPY)+0.85%

RS 6m (vs SPY)—

RS line new highNo

Trend template—

Technical rank89.1

1 week+5.08%

1 month+2.29%

3 months+5.34%

6 months—

1 year—

YTD+6.26%

P/E—

P/B—

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current—

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target35.50

Target upside16.85%

Analyst ratingBuy

Institutional48.96%

Ent. value2B

Revenue—

Net income—

Gross profit—

Free cash flow—

IndustryBiotechnology

ExchangeNasdaq

Shares out65.9M

Employees452

ListedThu, Dec 18, 2008

Free float474.38M

Float %100.0%

Short interest3.3M

Days to cover14.0d

Short volume66.3%

Squeeze score56 / 100

Next earnings—

EPS forecast—

Last EPS vs est$0.25 vs −$1.27

Last surprise+119.7% beat

Setup gradeB

Conviction66 / 100

Pattern quality—

Tech rank89.1 / 100

Group rank59 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance29.87

Support26.16

Days since event—

Candle confirm—

Signal lifecycle

How this symbol has moved through the lanes across 60 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

Broke out
Jul 7 – Jul 8
2 scans
→
Setting up
Aug 24 – Sep 3
6 scans

Congress activity

Disclosed STOCK Act trades in LKFT

All disclosures →

No recent disclosed trades by Congress in LKFT. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in LKFT

No recent insider (Form 4) filings in LKFT. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in LKFT · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.

LKFT

Signal lifecycle

Recent news

Get daily signals & real-time alerts.